Edvinsson L, Gross P M, Mohamed A
J Pharmacol Exp Ther. 1983 Apr;225(1):168-75.
Histamine is probably a mediator of vascular responses in the brain, but there is little experimental evidence for its importance in this role. By using both in vitro and in situ techniques, we have studied responses of cat pial arteries to stimulation of histamine receptors by pharmacological agents. In vitro, histamine and 2,2-pyridylethylamine (PEA, H1 agonist) caused contraction of resting arteries while impromidine (H2 agonist) was without effect. The PEA-induced constriction was blocked by the histamine H1 antagonist, mepyramine. When the arteries were precontracted (by 3 X 10(-6) M prostaglandin F2 alpha), however, all three agents caused vascular relaxation with an order of effectiveness as follows: histamine = impromidine much much greater than PEA. The responses of histamine and impromidine were reduced by the H2-antagonists, metiamide or cimetidine. Schild plots for the H2 receptor antagonists resulted in pA2 values of 6.90 and 7.03 for metiamide and cimetidine, respectively. In situ, neither agonist caused pial arterial constriction. Impromidine was considerably more effective than PEA in producing arterial dilatation. Metiamide reduced the effect of impromidine, whereas the dilatation of PEA was reduced by mepyramine. Dilatations resulting from PEA persisted in the presence of metiamide. Our results are consistent with the hypothesis that histamine H2 receptors are present in cerebral vascular smooth muscle as identified both in vitro and in situ. Indications for the additional presence of H1 receptors are, however, weak.
组胺可能是脑内血管反应的介质,但几乎没有实验证据表明其在这一作用中的重要性。通过使用体外和原位技术,我们研究了猫软脑膜动脉对药理学试剂刺激组胺受体的反应。在体外,组胺和2,2-吡啶基乙胺(PEA,H1激动剂)可使静息动脉收缩,而英普咪定(H2激动剂)则无作用。PEA诱导的收缩被组胺H1拮抗剂美吡拉敏阻断。然而,当动脉预先收缩(用3×10⁻⁶ M前列腺素F2α)时,所有三种试剂均引起血管舒张,其效力顺序如下:组胺 = 英普咪定 >> PEA。组胺和英普咪定的反应被H2拮抗剂甲硫米特或西咪替丁减弱。H2受体拮抗剂的施尔德图显示,甲硫米特和西咪替丁的pA2值分别为6.90和7.03。在原位,两种激动剂均未引起软脑膜动脉收缩。英普咪定在产生动脉扩张方面比PEA有效得多。甲硫米特降低了英普咪定的作用,而PEA引起的扩张被美吡拉敏减弱。在甲硫米特存在的情况下,PEA引起的扩张仍然存在。我们的结果与以下假设一致,即在体外和原位均已确定脑血管平滑肌中存在组胺H2受体。然而,存在H1受体的额外迹象并不明显。